|Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary|
J Vestbo, SS Hurd, AG Agustí, PW Jones, C Vogelmeier, A Anzueto, ...
American journal of respiratory and critical care medicine 187 (4), 347-365, 2013
|Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. GOLD executive summary|
CF Vogelmeier, GJ Criner, FJ Martinez, A Anzueto, PJ Barnes, ...
American journal of respiratory and critical care medicine 195 (5), 557-582, 2017
|Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive …|
DD Sin, SFP Man
Circulation 107 (11), 1514-1519, 2003
|Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease: the GOLD science committee report 2019|
D Singh, A Agusti, A Anzueto, PJ Barnes, J Bourbeau, BR Celli, GJ Criner, ...
European Respiratory Journal 53 (5), 2019
|Risk factors for central and obstructive sleep apnea in 450 men and women with congestive heart failure|
DD Sin, F Fitzgerald, JD Parker, G Newton, JS Floras, TD Bradley
American journal of respiratory and critical care medicine 160 (4), 1101-1106, 1999
|Mortality in COPD: role of comorbidities|
DD Sin, NR Anthonisen, JB Soriano, AG Agusti
European Respiratory Journal 28 (6), 1245-1257, 2006
|The relationship between reduced lung function and cardiovascular mortality: a population-based study and a systematic review of the literature|
DD Sin, LL Wu, SFP Man
Chest 127 (6), 1952-1959, 2005
|Small-airway obstruction and emphysema in chronic obstructive pulmonary disease|
JE McDonough, R Yuan, M Suzuki, N Seyednejad, WM Elliott, ...
New England Journal of Medicine 365 (17), 1567-1575, 2011
|Chronic obstructive pulmonary disease as a risk factor for cardiovascular morbidity and mortality|
DD Sin, SFP Man
Proceedings of the American Thoracic Society 2 (1), 8-11, 2005
|Effects of continuous positive airway pressure on cardiovascular outcomes in heart failure patients with and without Cheyne-Stokes respiration|
DD Sin, AG Logan, FS Fitzgerald, PP Liu, TD Bradley
Circulation 102 (1), 61-66, 2000
|Mapping the human genetic architecture of COVID-19|
Writing group Writing group leaders Pathak Gita A. 6 Andrews Shea J. 7 Kanai ...
Nature 600 (7889), 472-477, 2021
|Contemporary management of chronic obstructive pulmonary disease: scientific review|
DD Sin, FA McAlister, SFP Man, NR Anthonisen
Jama 290 (17), 2301-2312, 2003
|The lung tissue microbiome in chronic obstructive pulmonary disease|
MA Sze, PA Dimitriu, S Hayashi, WM Elliott, JE McDonough, JV Gosselink, ...
American journal of respiratory and critical care medicine 185 (10), 1073-1080, 2012
|Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease–2007 update|
DE O’donnell, S Aaron, J Bourbeau, P Hernandez, DD Marciniuk, ...
Canadian Respiratory Journal 14, 5B-32B, 2007
|An official American Thoracic Society/European Respiratory Society statement: research questions in chronic obstructive pulmonary disease|
BR Celli, M Decramer, JA Wedzicha, KC Wilson, A Agustí, GJ Criner, ...
American journal of respiratory and critical care medicine 191 (7), e4-e27, 2015
|Obesity is a risk factor for dyspnea but not for airflow obstruction|
DD Sin, RL Jones, SFP Man
Archives of internal medicine 162 (13), 1477-1481, 2002
|C-reactive protein and mortality in mild to moderate chronic obstructive pulmonary disease|
SFP Man, JE Connett, NR Anthonisen, RA Wise, DP Tashkin, DD Sin
Thorax 61 (10), 849-853, 2006
|Long-term compliance rates to continuous positive airway pressure in obstructive sleep apnea: a population-based study|
DD Sin, I Mayers, GCW Man, L Pawluk
Chest 121 (2), 430-435, 2002
|Effects of fluticasone on systemic markers of inflammation in chronic obstructive pulmonary disease|
DD Sin, P Lacy, E York, SFP Man
American journal of respiratory and critical care medicine 170 (7), 760-765, 2004
|The effects of inhaled corticosteroids in chronic obstructive pulmonary disease: a systematic review of randomized placebo-controlled trials|
A Alsaeedi, DD Sin, FA McAlister
The American journal of medicine 113 (1), 59-65, 2002